Walder Wyss advises Perconex Holding GmbH on the deal. The Frankfurt-based legal services company PERCONEX Holding GmbH announced the acquisition of Flex Suisse AG. Flex Suisse AG...
You must be a Standard 1 Year member to access this content.
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acted as legal advisor to Cawood Scientific. Walder Wyss advised IES’ shareholders in this transaction. Cawood Scientific, UK’s leading independent scientific group, announced...
You must be a Standard 1 Year member to access this content.
VISCHER AG advises Polyphor AG on the deal. Walder Wyss advises Enbiotix Inc. on this transaction. Polyphor (SIX: POLN) and EnBiotix Inc., a privately held late...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Alentis Therapeutics AG on the deal. Alentis Therapeutics AG announced a USD 67m series B financing round. Morningside Venture Investments led the financing, joined...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Dr. Wild & Co. AG in this transaction. Dr. Wild & Co. AG, the well-known Swiss family-owned company will focus on its Oral...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Dr. Wild & Co. AG in this transaction. Dr. Wild & Co. AG, the well-known Swiss family-owned company will focus on its Oral...
You must be a Standard 1 Year member to access this content.
